

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.82864719 |
| 2 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.82864719 |
| 3 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 7.08063948 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.05692776 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.08593543 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.08593543 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.08593543 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.96319438 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.69697643 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.64456834 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.61328756 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.27775536 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.21927772 |
| 14 | detection of other organism (GO:0098543) | 4.19525100 |
| 15 | detection of bacterium (GO:0016045) | 4.09971692 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.08165902 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.08102000 |
| 18 | negative T cell selection (GO:0043383) | 3.99974396 |
| 19 | response to peptidoglycan (GO:0032494) | 3.96871456 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.96211661 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.89518549 |
| 22 | response to type I interferon (GO:0034340) | 3.88782472 |
| 23 | cellular response to type I interferon (GO:0071357) | 3.82829103 |
| 24 | type I interferon signaling pathway (GO:0060337) | 3.82829103 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.79364177 |
| 26 | response to interleukin-15 (GO:0070672) | 3.76514995 |
| 27 | regulation of B cell differentiation (GO:0045577) | 3.70686902 |
| 28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.64910129 |
| 29 | T cell migration (GO:0072678) | 3.61146647 |
| 30 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.61092786 |
| 31 | thymic T cell selection (GO:0045061) | 3.57660303 |
| 32 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.57477173 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 3.56449484 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 3.54198383 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.52527658 |
| 36 | response to host immune response (GO:0052572) | 3.49636987 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49636987 |
| 38 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.49216555 |
| 39 | germinal center formation (GO:0002467) | 3.42602845 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.42111549 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.41369877 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.41369877 |
| 43 | response to host (GO:0075136) | 3.40601282 |
| 44 | response to host defenses (GO:0052200) | 3.40601282 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40601282 |
| 46 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40587084 |
| 47 | regulation of response to interferon-gamma (GO:0060330) | 3.34691240 |
| 48 | negative regulation of phagocytosis (GO:0050765) | 3.31903304 |
| 49 | T cell selection (GO:0045058) | 3.31731070 |
| 50 | B cell receptor signaling pathway (GO:0050853) | 3.28771169 |
| 51 | leukocyte aggregation (GO:0070486) | 3.27665730 |
| 52 | positive T cell selection (GO:0043368) | 3.26810262 |
| 53 | regulation of tolerance induction (GO:0002643) | 3.26371853 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.25726680 |
| 55 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23742946 |
| 56 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.23291652 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22856859 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 3.22719910 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22323166 |
| 60 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.21218892 |
| 61 | T cell homeostasis (GO:0043029) | 3.19701971 |
| 62 | negative regulation of bone resorption (GO:0045779) | 3.18476000 |
| 63 | interferon-gamma production (GO:0032609) | 3.17871407 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16556451 |
| 65 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.12682171 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 3.08246945 |
| 67 | tolerance induction (GO:0002507) | 3.06398169 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05858048 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.03962363 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03881407 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03844950 |
| 72 | response to interferon-beta (GO:0035456) | 3.00822495 |
| 73 | microglial cell activation (GO:0001774) | 2.99224403 |
| 74 | cellular extravasation (GO:0045123) | 2.98360544 |
| 75 | negative regulation of granulocyte differentiation (GO:0030853) | 2.98225484 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 2.96639003 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96560872 |
| 78 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.96022575 |
| 79 | macrophage activation (GO:0042116) | 2.93989062 |
| 80 | viral transcription (GO:0019083) | 2.92495295 |
| 81 | cellular response to interleukin-15 (GO:0071350) | 2.92197328 |
| 82 | positive regulation of tolerance induction (GO:0002645) | 2.91353594 |
| 83 | cellular response to interferon-beta (GO:0035458) | 2.91047851 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.88970253 |
| 85 | mast cell activation (GO:0045576) | 2.88942845 |
| 86 | positive regulation of interferon-alpha production (GO:0032727) | 2.86290171 |
| 87 | T cell costimulation (GO:0031295) | 2.84885489 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.84483115 |
| 89 | positive regulation of histone deacetylation (GO:0031065) | 2.84036928 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 2.83710459 |
| 91 | response to protozoan (GO:0001562) | 2.83122676 |
| 92 | lymphocyte homeostasis (GO:0002260) | 2.80968705 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.79691330 |
| 94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79475710 |
| 95 | neutrophil activation (GO:0042119) | 2.79429821 |
| 96 | lymphocyte costimulation (GO:0031294) | 2.79100143 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78126521 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78126521 |
| 99 | positive regulation of type 2 immune response (GO:0002830) | 2.77968355 |
| 100 | T cell receptor signaling pathway (GO:0050852) | 2.77965644 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.77660719 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77575998 |
| 103 | cellular response to zinc ion (GO:0071294) | 2.77495862 |
| 104 | cellular response to interferon-gamma (GO:0071346) | 2.76804219 |
| 105 | response to interferon-alpha (GO:0035455) | 2.76302931 |
| 106 | * regulation of antigen processing and presentation (GO:0002577) | 2.75757423 |
| 107 | positive regulation of interleukin-2 production (GO:0032743) | 2.74093995 |
| 108 | natural killer cell differentiation (GO:0001779) | 2.73090593 |
| 109 | T-helper 1 type immune response (GO:0042088) | 2.73074690 |
| 110 | translational termination (GO:0006415) | 2.72525387 |
| 111 | regulation of interferon-alpha production (GO:0032647) | 2.72327633 |
| 112 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.72095817 |
| 113 | B cell mediated immunity (GO:0019724) | 2.71983003 |
| 114 | defense response to protozoan (GO:0042832) | 2.69756889 |
| 115 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.69261348 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.69055284 |
| 117 | negative regulation of interleukin-6 production (GO:0032715) | 2.68937382 |
| 118 | regulation of natural killer cell differentiation (GO:0032823) | 2.68583771 |
| 119 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.68493021 |
| 120 | granulocyte activation (GO:0036230) | 2.68437276 |
| 121 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67873675 |
| 122 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67871992 |
| 123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67236920 |
| 124 | regulation of leukocyte degranulation (GO:0043300) | 2.66629854 |
| 125 | regulation of mast cell degranulation (GO:0043304) | 2.65406667 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.65323718 |
| 127 | definitive hemopoiesis (GO:0060216) | 2.62833116 |
| 128 | megakaryocyte development (GO:0035855) | 2.60293014 |
| 129 | leukocyte homeostasis (GO:0001776) | 2.59759208 |
| 130 | valine metabolic process (GO:0006573) | 2.55958282 |
| 131 | positive regulation of protein deacetylation (GO:0090312) | 2.54501209 |
| 132 | pentose-phosphate shunt (GO:0006098) | 2.54498271 |
| 133 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.54298621 |
| 134 | regulation of necroptotic process (GO:0060544) | 2.52690749 |
| 135 | angiogenesis involved in wound healing (GO:0060055) | 2.52608173 |
| 136 | natural killer cell activation (GO:0030101) | 2.52380881 |
| 137 | positive regulation of humoral immune response (GO:0002922) | 2.51869847 |
| 138 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.51412309 |
| 139 | mature B cell differentiation (GO:0002335) | 2.50615765 |
| 140 | lymph node development (GO:0048535) | 2.50215157 |
| 141 | regulation of hypersensitivity (GO:0002883) | 2.47518614 |
| 142 | regulation of regulatory T cell differentiation (GO:0045589) | 2.47226281 |
| 143 | negative regulation of innate immune response (GO:0045824) | 2.46883987 |
| 144 | Peyers patch development (GO:0048541) | 2.45680168 |
| 145 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.45680168 |
| 146 | JAK-STAT cascade (GO:0007259) | 2.45547608 |
| 147 | modulation by symbiont of host immune response (GO:0052553) | 2.44969530 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.44969530 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44969530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40758623 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.72705093 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.70331873 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.37872744 |
| 5 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.29127323 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.27383680 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15386542 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.10211927 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03664167 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.84378693 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81311182 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.81256495 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67884404 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.57316074 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53474622 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.45587977 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43785896 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.42952500 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.36601342 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32054133 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29977291 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26257311 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26175520 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25778509 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21974218 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16774068 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.13628798 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08320686 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07350003 |
| 30 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.06699179 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 2.06639983 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03591025 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01240413 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.00108083 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.97822129 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97501201 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94777687 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93842479 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83444238 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80315605 |
| 41 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79737284 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78271045 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76110022 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.75434814 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72868248 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72106707 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71089061 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66077830 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.60628631 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57059527 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54502550 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51334930 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51240206 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47389679 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44618084 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43133840 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43115482 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43108414 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41632311 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40516124 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39618792 |
| 62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39412252 |
| 63 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38219471 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31820083 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31757718 |
| 66 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30991585 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30449616 |
| 68 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24287393 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24046601 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22935407 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21243171 |
| 72 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20712655 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20494518 |
| 74 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19630407 |
| 75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19398065 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18829121 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17277356 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16535046 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16512009 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15234528 |
| 81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14954767 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13428629 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11867042 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11842403 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09878732 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08753267 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08301042 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08225038 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04633328 |
| 90 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04460580 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01430344 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01148550 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99295347 |
| 94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99158667 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98983359 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95982307 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95630952 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94693288 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94689747 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94062714 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92640134 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90794587 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89297446 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88356658 |
| 105 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87276996 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87169138 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87034929 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85763598 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84988148 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84648332 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84140240 |
| 112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83905750 |
| 113 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83285306 |
| 114 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82986226 |
| 115 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81912246 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81666618 |
| 117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81152794 |
| 118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80905224 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80858892 |
| 120 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.80620521 |
| 121 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80305062 |
| 122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.79505746 |
| 123 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77821859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 3.74099930 |
| 2 | MP0000685_abnormal_immune_system | 3.39152000 |
| 3 | MP0005671_abnormal_response_to | 2.97068201 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.95090719 |
| 5 | MP0009785_altered_susceptibility_to | 2.79672580 |
| 6 | MP0001800_abnormal_humoral_immune | 2.77402751 |
| 7 | MP0005387_immune_system_phenotype | 2.74820182 |
| 8 | MP0001790_abnormal_immune_system | 2.74820182 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.66810337 |
| 10 | MP0003436_decreased_susceptibility_to | 2.61838647 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.58112232 |
| 12 | MP0003303_peritoneal_inflammation | 2.56565182 |
| 13 | MP0003724_increased_susceptibility_to | 2.56079187 |
| 14 | MP0005025_abnormal_response_to | 2.51100758 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.47692325 |
| 16 | MP0005451_abnormal_body_composition | 2.45980882 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.41046506 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.39525973 |
| 19 | MP0002723_abnormal_immune_serum | 2.37643468 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.32608596 |
| 21 | * MP0001819_abnormal_immune_cell | 2.30649591 |
| 22 | MP0002398_abnormal_bone_marrow | 2.22888540 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.19422855 |
| 24 | MP0002419_abnormal_innate_immunity | 2.18144283 |
| 25 | MP0001873_stomach_inflammation | 2.11044291 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.00681664 |
| 27 | * MP0000716_abnormal_immune_system | 2.00422196 |
| 28 | MP0004947_skin_inflammation | 1.96320649 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.95763502 |
| 30 | MP0002006_tumorigenesis | 1.93005395 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.92167401 |
| 32 | MP0002405_respiratory_system_inflammati | 1.91892487 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.88845306 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.88845306 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.85986826 |
| 36 | MP0001853_heart_inflammation | 1.84703544 |
| 37 | MP0002722_abnormal_immune_system | 1.84421584 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.83216572 |
| 39 | MP0006082_CNS_inflammation | 1.75790017 |
| 40 | MP0004510_myositis | 1.75618232 |
| 41 | MP0009278_abnormal_bone_marrow | 1.75086328 |
| 42 | * MP0002429_abnormal_blood_cell | 1.73263432 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.72134796 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.71177957 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.71050881 |
| 46 | MP0008260_abnormal_autophagy | 1.63303697 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.59281949 |
| 48 | MP0009840_abnormal_foam_cell | 1.58600190 |
| 49 | MP0003866_abnormal_defecation | 1.56596226 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.46329422 |
| 51 | MP0008469_abnormal_protein_level | 1.45217042 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.37770988 |
| 53 | MP0002933_joint_inflammation | 1.26905381 |
| 54 | MP0000858_altered_metastatic_potential | 1.26044511 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.23399180 |
| 56 | MP0003091_abnormal_cell_migration | 1.21650499 |
| 57 | MP0000490_abnormal_crypts_of | 1.16768388 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.16237279 |
| 59 | MP0004381_abnormal_hair_follicle | 1.15478747 |
| 60 | MP0003448_altered_tumor_morphology | 1.13448787 |
| 61 | MP0005310_abnormal_salivary_gland | 1.12608834 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.11703448 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.10433392 |
| 64 | MP0009764_decreased_sensitivity_to | 1.05601806 |
| 65 | MP0001851_eye_inflammation | 1.04574791 |
| 66 | MP0000343_altered_response_to | 1.02998895 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.01966686 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.01564621 |
| 69 | MP0000609_abnormal_liver_physiology | 0.98336386 |
| 70 | MP0005360_urolithiasis | 0.96011658 |
| 71 | MP0005023_abnormal_wound_healing | 0.93424711 |
| 72 | MP0009763_increased_sensitivity_to | 0.92349466 |
| 73 | MP0002254_reproductive_system_inflammat | 0.92200158 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.92079425 |
| 75 | MP0003045_fibrosis | 0.86288591 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.85556968 |
| 77 | MP0005164_abnormal_response_to | 0.85411011 |
| 78 | MP0010307_abnormal_tumor_latency | 0.82570255 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.81894323 |
| 80 | MP0004883_abnormal_blood_vessel | 0.81779266 |
| 81 | MP0006054_spinal_hemorrhage | 0.80251522 |
| 82 | MP0005365_abnormal_bile_salt | 0.78799692 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.77217206 |
| 84 | MP0005390_skeleton_phenotype | 0.74468156 |
| 85 | MP0001663_abnormal_digestive_system | 0.73790011 |
| 86 | MP0003795_abnormal_bone_structure | 0.73606241 |
| 87 | MP0003075_altered_response_to | 0.73384900 |
| 88 | MP0000249_abnormal_blood_vessel | 0.73148385 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.71551088 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.70815881 |
| 91 | MP0000598_abnormal_liver_morphology | 0.70340395 |
| 92 | MP0003828_pulmonary_edema | 0.70037077 |
| 93 | MP0008004_abnormal_stomach_pH | 0.69587934 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.69471701 |
| 95 | MP0002796_impaired_skin_barrier | 0.68955278 |
| 96 | MP0003690_abnormal_glial_cell | 0.68557195 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.67927883 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.67636868 |
| 99 | MP0002132_abnormal_respiratory_system | 0.67198304 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.66599336 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65972387 |
| 102 | MP0004130_abnormal_muscle_cell | 0.65438891 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.65144362 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.64436439 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.64367747 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.63256669 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.63224347 |
| 108 | MP0002139_abnormal_hepatobiliary_system | 0.62969051 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.62500692 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.62022555 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.61738619 |
| 112 | MP0001849_ear_inflammation | 0.60646322 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60213392 |
| 114 | MP0000604_amyloidosis | 0.58997151 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.58464371 |
| 116 | MP0008874_decreased_physiological_sensi | 0.57892638 |
| 117 | MP0005166_decreased_susceptibility_to | 0.57057274 |
| 118 | MP0001881_abnormal_mammary_gland | 0.56316935 |
| 119 | MP0008873_increased_physiological_sensi | 0.55015121 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.54948264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.90414593 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.72227415 |
| 3 | * Chronic otitis media (HP:0000389) | 4.56295122 |
| 4 | Recurrent viral infections (HP:0004429) | 4.22184603 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.14582566 |
| 6 | IgM deficiency (HP:0002850) | 4.12966210 |
| 7 | Myositis (HP:0100614) | 4.09793125 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.01250592 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.87158140 |
| 10 | * Nasal polyposis (HP:0100582) | 3.81707232 |
| 11 | Thrombocytosis (HP:0001894) | 3.81600732 |
| 12 | * Abnormality of the nasal mucosa (HP:0000433) | 3.78150618 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.73828969 |
| 14 | * Recurrent bronchitis (HP:0002837) | 3.65929186 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.57579339 |
| 16 | T lymphocytopenia (HP:0005403) | 3.53820439 |
| 17 | Abnormality of T cells (HP:0002843) | 3.52036511 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.45863943 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.42792329 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.42779372 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.36351203 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.36351203 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.34682046 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 3.31511785 |
| 25 | Increased IgE level (HP:0003212) | 3.30949497 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.29839983 |
| 27 | Colitis (HP:0002583) | 3.25188479 |
| 28 | Meningitis (HP:0001287) | 3.16166058 |
| 29 | Cellulitis (HP:0100658) | 3.13813402 |
| 30 | Recurrent skin infections (HP:0001581) | 3.13616379 |
| 31 | Pustule (HP:0200039) | 3.10195646 |
| 32 | Prolonged bleeding time (HP:0003010) | 2.98532486 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.97363166 |
| 34 | Petechiae (HP:0000967) | 2.91470264 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.90004243 |
| 36 | Increased IgM level (HP:0003496) | 2.87909119 |
| 37 | Epistaxis (HP:0000421) | 2.84920865 |
| 38 | Vasculitis (HP:0002633) | 2.84759952 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.83932196 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.72697403 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.71669089 |
| 42 | Gingival bleeding (HP:0000225) | 2.69303171 |
| 43 | Orchitis (HP:0100796) | 2.69192361 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.69138358 |
| 45 | B lymphocytopenia (HP:0010976) | 2.69138358 |
| 46 | Impaired platelet aggregation (HP:0003540) | 2.65021228 |
| 47 | Abnormal platelet function (HP:0011869) | 2.65021228 |
| 48 | Lymphopenia (HP:0001888) | 2.63157429 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.61528108 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.60246070 |
| 51 | Eosinophilia (HP:0001880) | 2.57901632 |
| 52 | Granulocytopenia (HP:0001913) | 2.55762527 |
| 53 | Abnormality of the fingertips (HP:0001211) | 2.54839327 |
| 54 | Leukocytosis (HP:0001974) | 2.51974602 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.51516206 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.45056571 |
| 57 | Viral hepatitis (HP:0006562) | 2.44400236 |
| 58 | IgG deficiency (HP:0004315) | 2.42313737 |
| 59 | Severe combined immunodeficiency (HP:0004430) | 2.42145604 |
| 60 | Stomatitis (HP:0010280) | 2.41454480 |
| 61 | Hematochezia (HP:0002573) | 2.40561064 |
| 62 | Hemoptysis (HP:0002105) | 2.40253486 |
| 63 | Combined immunodeficiency (HP:0005387) | 2.40089208 |
| 64 | Verrucae (HP:0200043) | 2.39847412 |
| 65 | Papilloma (HP:0012740) | 2.39847412 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.36502223 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35493718 |
| 68 | Obstructive lung disease (HP:0006536) | 2.35493718 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.35460849 |
| 70 | Achilles tendon contracture (HP:0001771) | 2.35131652 |
| 71 | Encephalitis (HP:0002383) | 2.34582055 |
| 72 | Arterial thrombosis (HP:0004420) | 2.34440560 |
| 73 | Gastrointestinal stroma tumor (HP:0100723) | 2.33816388 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.33517043 |
| 75 | Thyroiditis (HP:0100646) | 2.31615856 |
| 76 | Periodontitis (HP:0000704) | 2.30318494 |
| 77 | Subacute progressive viral hepatitis (HP:0006572) | 2.27983357 |
| 78 | Chest pain (HP:0100749) | 2.26859315 |
| 79 | Malnutrition (HP:0004395) | 2.25195140 |
| 80 | Osteomyelitis (HP:0002754) | 2.24553447 |
| 81 | Basal ganglia calcification (HP:0002135) | 2.24029092 |
| 82 | Joint swelling (HP:0001386) | 2.21867493 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.21748123 |
| 84 | Chronic diarrhea (HP:0002028) | 2.21169354 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.20974055 |
| 86 | IgA deficiency (HP:0002720) | 2.18800148 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 2.17069062 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 2.15295593 |
| 89 | Optic neuritis (HP:0100653) | 2.14957675 |
| 90 | Retrobulbar optic neuritis (HP:0100654) | 2.14957675 |
| 91 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.14716514 |
| 92 | * Skin ulcer (HP:0200042) | 2.14703480 |
| 93 | Fatigue (HP:0012378) | 2.12250095 |
| 94 | Pulmonary embolism (HP:0002204) | 2.11579197 |
| 95 | Hypertriglyceridemia (HP:0002155) | 2.11264752 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 2.10194286 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.08799193 |
| 98 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.08696501 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 2.08287260 |
| 100 | Abnormal number of erythroid precursors (HP:0012131) | 2.06163820 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.05225748 |
| 102 | Premature loss of primary teeth (HP:0006323) | 2.03285955 |
| 103 | Abnormality of the peritoneum (HP:0002585) | 2.03040995 |
| 104 | Peritonitis (HP:0002586) | 2.02955957 |
| 105 | Purpura (HP:0000979) | 2.01574096 |
| 106 | * Emphysema (HP:0002097) | 2.00383953 |
| 107 | Microcytic anemia (HP:0001935) | 1.99489378 |
| 108 | Increased serum ferritin (HP:0003281) | 1.98573135 |
| 109 | Bone pain (HP:0002653) | 1.98566795 |
| 110 | Gingivitis (HP:0000230) | 1.98285295 |
| 111 | Sepsis (HP:0100806) | 1.97659072 |
| 112 | Skin rash (HP:0000988) | 1.97437045 |
| 113 | Large eyes (HP:0001090) | 1.97310196 |
| 114 | Loss of speech (HP:0002371) | 1.97264025 |
| 115 | Urticaria (HP:0001025) | 1.96501830 |
| 116 | * Chronic sinusitis (HP:0011109) | 1.96474543 |
| 117 | Gangrene (HP:0100758) | 1.95969661 |
| 118 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95846756 |
| 119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95846756 |
| 120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95846756 |
| 121 | Recurrent sinusitis (HP:0011108) | 1.95565085 |
| 122 | * Bronchitis (HP:0012387) | 1.95550833 |
| 123 | Slow saccadic eye movements (HP:0000514) | 1.94691877 |
| 124 | Lymphoma (HP:0002665) | 1.93886611 |
| 125 | Restrictive lung disease (HP:0002091) | 1.92521418 |
| 126 | Amyloidosis (HP:0011034) | 1.91805389 |
| 127 | Menorrhagia (HP:0000132) | 1.90081131 |
| 128 | Glomerulopathy (HP:0100820) | 1.89567942 |
| 129 | Increased mean platelet volume (HP:0011877) | 1.89249642 |
| 130 | Acute hepatic failure (HP:0006554) | 1.88893480 |
| 131 | Arthralgia (HP:0002829) | 1.88257832 |
| 132 | Anorexia (HP:0002039) | 1.85780138 |
| 133 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85562918 |
| 134 | Abnormality of the pleura (HP:0002103) | 1.85153173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.66058737 |
| 2 | PRPF4B | 3.34070080 |
| 3 | TYK2 | 2.93602387 |
| 4 | EEF2K | 2.93160722 |
| 5 | KIT | 2.78036391 |
| 6 | JAK3 | 2.71241297 |
| 7 | ERN1 | 2.55203419 |
| 8 | FGFR4 | 2.47615681 |
| 9 | TBK1 | 2.39883368 |
| 10 | TXK | 2.29064023 |
| 11 | ZAP70 | 2.25724875 |
| 12 | IKBKE | 2.21072500 |
| 13 | PKN2 | 2.20066598 |
| 14 | TRIB3 | 2.14178284 |
| 15 | BTK | 2.05763649 |
| 16 | BLK | 2.04240807 |
| 17 | JAK1 | 1.96723938 |
| 18 | GRK7 | 1.86277423 |
| 19 | FLT3 | 1.85625787 |
| 20 | MAP3K14 | 1.84801131 |
| 21 | STK10 | 1.84229722 |
| 22 | MOS | 1.83584439 |
| 23 | EPHB1 | 1.82863394 |
| 24 | TEC | 1.80337440 |
| 25 | GRK6 | 1.79789127 |
| 26 | CSF1R | 1.72113436 |
| 27 | ITK | 1.71219851 |
| 28 | SMG1 | 1.65343313 |
| 29 | LRRK2 | 1.64876580 |
| 30 | TGFBR2 | 1.62934145 |
| 31 | MAP3K10 | 1.62230434 |
| 32 | KDR | 1.61396233 |
| 33 | SYK | 1.59652396 |
| 34 | NME2 | 1.53873916 |
| 35 | TAOK3 | 1.52048384 |
| 36 | IRAK4 | 1.48174033 |
| 37 | FGFR3 | 1.47986956 |
| 38 | MAP2K3 | 1.37334852 |
| 39 | LCK | 1.32231844 |
| 40 | IKBKB | 1.29489776 |
| 41 | CDK12 | 1.26644577 |
| 42 | CSK | 1.25762136 |
| 43 | HCK | 1.24626496 |
| 44 | NLK | 1.24357848 |
| 45 | FES | 1.21569943 |
| 46 | SIK1 | 1.20038863 |
| 47 | PIM2 | 1.17505825 |
| 48 | EPHA3 | 1.14662521 |
| 49 | TAOK2 | 1.13738251 |
| 50 | TAOK1 | 1.10911264 |
| 51 | IRAK3 | 1.10871856 |
| 52 | CDC42BPA | 1.10465968 |
| 53 | JAK2 | 1.08790520 |
| 54 | PTK6 | 1.07564111 |
| 55 | FGR | 1.04355188 |
| 56 | RPS6KA4 | 1.02820010 |
| 57 | MAP3K13 | 1.01339272 |
| 58 | PIM1 | 1.00345190 |
| 59 | KSR2 | 0.96258530 |
| 60 | TGFBR1 | 0.94856268 |
| 61 | SIK2 | 0.90139484 |
| 62 | LYN | 0.88796382 |
| 63 | MAPKAPK3 | 0.88604192 |
| 64 | MST1R | 0.88443266 |
| 65 | RPS6KB2 | 0.85608802 |
| 66 | TTN | 0.85062044 |
| 67 | ICK | 0.85055280 |
| 68 | CLK1 | 0.81886049 |
| 69 | IRAK2 | 0.78585273 |
| 70 | BMPR2 | 0.78209014 |
| 71 | CHUK | 0.76731146 |
| 72 | TIE1 | 0.74154329 |
| 73 | SCYL2 | 0.72226266 |
| 74 | MST4 | 0.71988958 |
| 75 | CDK4 | 0.66850490 |
| 76 | RIPK4 | 0.66129984 |
| 77 | MAPK11 | 0.66124445 |
| 78 | PDPK1 | 0.65239974 |
| 79 | MARK3 | 0.64790655 |
| 80 | MAP3K6 | 0.63873513 |
| 81 | MARK2 | 0.63361717 |
| 82 | MAPK7 | 0.62071842 |
| 83 | MAP3K7 | 0.61538075 |
| 84 | BCKDK | 0.60290902 |
| 85 | YES1 | 0.59488137 |
| 86 | TRPM7 | 0.58780487 |
| 87 | HIPK2 | 0.58628023 |
| 88 | MATK | 0.56985034 |
| 89 | PRKD2 | 0.56640508 |
| 90 | MAPK4 | 0.56050078 |
| 91 | GRK5 | 0.54050765 |
| 92 | TESK2 | 0.52559519 |
| 93 | MAP3K11 | 0.50499195 |
| 94 | MAP3K2 | 0.50102209 |
| 95 | PRKCQ | 0.49947180 |
| 96 | TNK2 | 0.47509505 |
| 97 | PTK2 | 0.46440660 |
| 98 | PRKCH | 0.45924159 |
| 99 | STK4 | 0.45735953 |
| 100 | RPS6KA6 | 0.45316582 |
| 101 | CDK6 | 0.43266465 |
| 102 | NEK2 | 0.42959072 |
| 103 | MAPKAPK2 | 0.41493689 |
| 104 | PAK4 | 0.40525266 |
| 105 | RAF1 | 0.39652759 |
| 106 | MAP3K3 | 0.39207574 |
| 107 | CAMK1D | 0.38071993 |
| 108 | RET | 0.37870285 |
| 109 | PDK1 | 0.37627188 |
| 110 | FYN | 0.37075654 |
| 111 | MAP3K8 | 0.36961898 |
| 112 | PDGFRA | 0.36902163 |
| 113 | BMX | 0.36228387 |
| 114 | RIPK1 | 0.35941959 |
| 115 | MELK | 0.35558531 |
| 116 | PASK | 0.34754233 |
| 117 | RPS6KL1 | 0.34150231 |
| 118 | RPS6KC1 | 0.34150231 |
| 119 | ABL1 | 0.32726503 |
| 120 | NEK9 | 0.32587648 |
| 121 | SIK3 | 0.32401297 |
| 122 | ALK | 0.32266989 |
| 123 | SGK3 | 0.31364602 |
| 124 | IRAK1 | 0.29992913 |
| 125 | MAPK12 | 0.28640250 |
| 126 | EGFR | 0.28502342 |
| 127 | PRKG2 | 0.28104227 |
| 128 | MAPK3 | 0.27128127 |
| 129 | MAP3K1 | 0.25360750 |
| 130 | PIK3CG | 0.25182471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 3.77450359 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62041733 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.48981611 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46289661 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.40742454 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32761245 |
| 7 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25945570 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23887558 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23037099 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.00749529 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.00548160 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.96106033 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93591867 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93412877 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93203904 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.93165553 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.82557948 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79713109 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73675096 |
| 20 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.70906549 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70449440 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68580961 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.56432068 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.53145356 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.49034202 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43760499 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.39864883 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.38346785 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35662981 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.33916583 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33146023 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.31295223 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.29336194 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.26089866 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25354871 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24393403 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21829538 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.21490382 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20861135 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.16331072 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15897707 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14403161 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12830050 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12564980 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.04881542 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.04345866 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03974554 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02295170 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01349396 |
| 50 | * Phagosome_Homo sapiens_hsa04145 | 1.01009659 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00084954 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96006309 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90064366 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89380824 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88958583 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86788864 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86702317 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85445582 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81922348 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77753523 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75713611 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75316942 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.74437788 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 0.73537116 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.73266473 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73220961 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71892309 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70353872 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68857037 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68554649 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67912848 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.65938558 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64589299 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63162895 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61442957 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61436433 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60838177 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.60063839 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59305101 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59102970 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.58968325 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57931382 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57879037 |
| 84 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57824002 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57669917 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.57061708 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55796078 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55360264 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53603129 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52997755 |
| 91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52736235 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52370852 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51776246 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51287760 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50952202 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.49923948 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49659862 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47496353 |
| 99 | * ABC transporters_Homo sapiens_hsa02010 | 0.47362413 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.47236166 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47096090 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46073757 |
| 103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42563833 |
| 104 | Glioma_Homo sapiens_hsa05214 | 0.41224382 |
| 105 | Mismatch repair_Homo sapiens_hsa03430 | 0.41101942 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40406580 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39705225 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39238059 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38706666 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38435274 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37394059 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37169171 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36632401 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36473980 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36225020 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36094633 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35801887 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35613908 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.35507483 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35468658 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35188350 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34146581 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33470861 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32582750 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31416446 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30682692 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.30595305 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.28625532 |

